At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,022 enrolled
Drug / intervention
Trifecta Aortic Heart Valvedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Observational, Prospective Evaluation of the Trifecta Valve
In Brief
A clinical study evaluating Trifecta Aortic Heart Valve for Aortic Valve Insufficiency and 3 related conditions. Completed, enrolled 1,022 participants across 18 sites.
Detailed Summary
To confirm the clinical safety and effectiveness of the Trifecta valve.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Valve Insufficiency, Regurgitation, Aortic Valve, Aortic Valve Incompetence, Aortic Valve Stenosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 2007
Enrollment StartJun 2007
Primary CompletionJul 2010
Study CompletionJan 2012
TodayJul 2026
First PostedMay 21, 2007
Enrollment StartJun 1, 2007
Primary CompletionJul 1, 2010
Study CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 19.1 years ago
Interventions
Trifecta Aortic Heart Valvedevice
Surgical replacement of the aortic valve with the Trifecta Aortic Heart Valve.